Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2737751 | Diagnostic and Interventional Imaging | 2015 | 12 Pages |
Abstract
Interventional radiology is involved practically at each stage in the treatment of hepatocellular carcinoma, as recommended in the EASL-EORTC guidelines. It is even becoming more important as technological advances progress and as its long-term efficacy is assessed. Used curatively, thermoablation can obtain five-year survival rates of 40 to 70%, with a survival rate of 30% at 10 years. As there are many tools available in order to be used, it requires a thorough pre-treatment assessment and discussion in a multidisciplinary team meeting. Regular patient reassessment is needed in order to be able to adjust treatment because of the complementarity of the treatments available and the course of the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Health Informatics
Authors
C. Aubé, A. Bouvier, J. Lebigot, L. Vervueren, V. Cartier, F. Oberti,